ArticleKidney3602026

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights.

Kana N Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.